Jane Street
IGC icon

Jane Street’s IGC Pharma IGC Stock Holding History

Jane Street’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,600
Closed -$17K – 10408
2021
Q3 		$17K Buy
+11,600
New +$18.8K ﹤0.01% 9763

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Jane Street's IGC Position: Q2 2026 in Review

Jane Street opened a new position in IGC Pharma (IGC) in Q2 2026: 62,610 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #11243 among its holdings. This is a return to the name: Jane Street previously reported a position in IGC as recently as Q2 2025.

Jane Street first reported a position in IGC in Q3 2018 and has held it in 15 quarters since. The position peaked at $137K in Q3 2018. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Jane Street held 62,610 shares of IGC Pharma worth $17K as of Q2 2026.
  • IGC Pharma was a new Jane Street position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11243 holding.
  • Jane Street first reported a position in IGC Pharma in Q3 2018 and has held it in 15 quarters since.
  • Jane Street's IGC Pharma position peaked at $137K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.